Rachel Wollacott

Rachel Wollacott is an experienced professional in the field of bioprocessing and pharmaceutical development, currently serving as Senior Director of CMC Tech Ops at Arbor Biotechnologies since April 2022. Rachel has a robust consulting background as a CMC Consultant since July 2019 and previously held senior leadership roles, including Senior Director of Process Development and Manufacturing at PROTHELIA INCORPORATED, and Senior Director of Process Development at Iveric Bio. With expertise in process development, manufacturing, and regulatory compliance, Rachel has led significant programs, ensuring timely production and quality standards while managing relationships with contract manufacturing and research organizations. Rachel's foundational experience includes roles at MassBiologics and a postdoctoral fellowship at the Massachusetts Institute of Technology. Rachel holds a Ph.D. in Chemistry from Penn State University and a BS in Biochemistry from Providence College.